Cargando…
Illuminating the mechanism of IL-6-mediated immunotherapy resistance
Huseni et al. report that IL-6-STAT3 signaling negatively impacts the anti-tumor function of cytotoxic T cells. Targeting IL-6 signaling may enhance tumor responses to immune checkpoint blockade therapy.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873941/ https://www.ncbi.nlm.nih.gov/pubmed/36652910 http://dx.doi.org/10.1016/j.xcrm.2022.100901 |